Abstract
A strategy for increasing the expression of the factors regulating myogenesis was developed based upon the observation that increased amounts of regulatory factors could overcome the inhibition of differentiation produced by 5-bromodeoxyuridine (BUdR). L6 rat myoblasts were subjected to multiple cycles of cloning in progressively increasing concentrations of BUdR. The first clones to differentiate were picked and replated for the next cycle of selection. After 28 cycles in BUdR, cells were isolated that could differentiate in the presence of 8 microM BUdR. Cell hybrids between myoblasts subjected to 21 cycles of selection (BU21 cells) and differentiation-defective myoblasts exhibited a high probability of differentiation, consistent with the hypothesis that BU21 cells were overproducing factor(s) involved in the decision to differentiate. The selection of cells able to differentiate in the presence of BUdR may provide a general approach for increasing the expression of the regulatory molecules controlling terminal differentiation.
Full Text
The Full Text of this article is available as a PDF (872.4 KB).
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Abbott J., Holtzer H. The loss of phenotypic traits by differentiated cells, V. The effect of 5-bromodeoxyuridine on cloned chondrocytes. Proc Natl Acad Sci U S A. 1968 Apr;59(4):1144–1151. doi: 10.1073/pnas.59.4.1144. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Clark W. A., Jr, Chizzonite R. A., Everett A. W., Rabinowitz M., Zak R. Species correlations between cardiac isomyosins. A comparison of electrophoretic and immunological properties. J Biol Chem. 1982 May 25;257(10):5449–5454. [PubMed] [Google Scholar]
- Coleman A. W., Coleman J. R., Kankel D., Werner I. The reversible control of animal cell differentiation by the thymidine analog, 5-bromodeoxyuridine. Exp Cell Res. 1970 Feb;59(2):319–328. doi: 10.1016/0014-4827(70)90606-3. [DOI] [PubMed] [Google Scholar]
- Mandel J. L., Pearson M. L. Insulin stimulates myogenesis in a rat myoblast line. Nature. 1974 Oct 18;251(5476):618–620. doi: 10.1038/251618a0. [DOI] [PubMed] [Google Scholar]
- Meuth M., Green H. Induction of a deoxycytidineless state in cultured mammalian cells by bromodeoxyuridine. Cell. 1974 Jun;2(2):109–112. doi: 10.1016/0092-8674(74)90099-3. [DOI] [PubMed] [Google Scholar]
- Peterson J. A. Analysis of variability in albumin content of sister hepatoma cells and a model for geometric phenotypic variability (quantitative shift model). Somat Cell Mol Genet. 1984 Jul;10(4):345–357. doi: 10.1007/BF01535630. [DOI] [PubMed] [Google Scholar]
- Peterson J. A., Chaovapong W. L., Dehgnan A. A. Quantitative phenotypic variation in single normal and malignant cells from liver and breast occurs along a geometric series. Somat Cell Mol Genet. 1984 Jul;10(4):331–344. doi: 10.1007/BF01535629. [DOI] [PubMed] [Google Scholar]
- Peterson J. A. The widespread nature of phenotypic variability in hepatomas and cell lines, in the form of a geometric series. J Theor Biol. 1983 May 7;102(1):41–53. doi: 10.1016/0022-5193(83)90261-8. [DOI] [PubMed] [Google Scholar]
- Schimke R. T. Gene amplification in cultured animal cells. Cell. 1984 Jul;37(3):705–713. doi: 10.1016/0092-8674(84)90406-9. [DOI] [PubMed] [Google Scholar]
- Silagi S., Bruce S. A. Suppression of malignancy and differentiation in melanotic melanoma cells. Proc Natl Acad Sci U S A. 1970 May;66(1):72–78. doi: 10.1073/pnas.66.1.72. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Turkington R. W., Majumder G. C., Riddle M. Inhibition of mammary gland differentiation in vitro by 5-bromo-2'-deoxyuridine. J Biol Chem. 1971 Mar 25;246(6):1814–1819. [PubMed] [Google Scholar]
- WESSELLS N. K. DNA SYNTHESIS, MITOSIS, AND DIFFERENTIATION IN PANCREATIC ACINAR CELLS IN VITRO. J Cell Biol. 1964 Mar;20:415–433. doi: 10.1083/jcb.20.3.415. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Weintraub H., Campbell G. L., Holtzer H. Identification of a developmental program using bromodeoxyuridine. J Mol Biol. 1972 Sep 28;70(2):337–350. doi: 10.1016/0022-2836(72)90543-8. [DOI] [PubMed] [Google Scholar]
- Wright W. E., Aronoff J. Regulation of rat myosin light-chain synthesis in heterokaryons between 5-bromodeoxyuridine-blocked rat myoblasts and differentiated chick myocytes. J Cell Biol. 1983 Jun;96(6):1571–1579. doi: 10.1083/jcb.96.6.1571. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Wright W. E. Control of differentiation in heterokaryons and hybrids involving differentiation-defective myoblast variants. J Cell Biol. 1984 Feb;98(2):436–443. doi: 10.1083/jcb.98.2.436. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Wright W. E., Gros F. Coexpression of myogenic functions in L6 rat x T984 mouse myoblast hybrids. Dev Biol. 1981 Aug;86(1):236–240. doi: 10.1016/0012-1606(81)90335-3. [DOI] [PubMed] [Google Scholar]
- Wright W. E. Synthesis of rat myosin light chains in heterokaryons formed between undifferentiated rat myoblasts and chick skeletal myocytes. J Cell Biol. 1981 Oct;91(1):11–16. doi: 10.1083/jcb.91.1.11. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Wright W. E. The BrdU content of DNA is decreased during reversal of inhibition of myogenesis by deoxycytidine. Somatic Cell Genet. 1982 Sep;8(5):547–555. doi: 10.1007/BF01542850. [DOI] [PubMed] [Google Scholar]
- Wright W. E. The isolation of heterokaryons and hybrids by a selective system using irreversible biochemical inhibitors. Exp Cell Res. 1978 Mar 15;112(2):395–407. doi: 10.1016/0014-4827(78)90222-7. [DOI] [PubMed] [Google Scholar]
- Yaffe D. Retention of differentiation potentialities during prolonged cultivation of myogenic cells. Proc Natl Acad Sci U S A. 1968 Oct;61(2):477–483. doi: 10.1073/pnas.61.2.477. [DOI] [PMC free article] [PubMed] [Google Scholar]